Cargando…
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393248/ https://www.ncbi.nlm.nih.gov/pubmed/32736573 http://dx.doi.org/10.1186/s13054-020-03195-9 |
_version_ | 1783565006541946880 |
---|---|
author | Onweni, Chidinma L. Zhang, Yu Shrike Caulfield, Thomas Hopkins, Christopher E. Fairweather, De Lisa Freeman, William D. |
author_facet | Onweni, Chidinma L. Zhang, Yu Shrike Caulfield, Thomas Hopkins, Christopher E. Fairweather, De Lisa Freeman, William D. |
author_sort | Onweni, Chidinma L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7393248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73932482020-07-31 ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking Onweni, Chidinma L. Zhang, Yu Shrike Caulfield, Thomas Hopkins, Christopher E. Fairweather, De Lisa Freeman, William D. Crit Care Research Letter BioMed Central 2020-07-31 /pmc/articles/PMC7393248/ /pubmed/32736573 http://dx.doi.org/10.1186/s13054-020-03195-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Letter Onweni, Chidinma L. Zhang, Yu Shrike Caulfield, Thomas Hopkins, Christopher E. Fairweather, De Lisa Freeman, William D. ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title | ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title_full | ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title_fullStr | ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title_full_unstemmed | ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title_short | ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking |
title_sort | acei/arb therapy in covid-19: the double-edged sword of ace2 and sars-cov-2 viral docking |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393248/ https://www.ncbi.nlm.nih.gov/pubmed/32736573 http://dx.doi.org/10.1186/s13054-020-03195-9 |
work_keys_str_mv | AT onwenichidinmal aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking AT zhangyushrike aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking AT caulfieldthomas aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking AT hopkinschristophere aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking AT fairweatherdelisa aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking AT freemanwilliamd aceiarbtherapyincovid19thedoubleedgedswordoface2andsarscov2viraldocking |